Department of Medicine, Institute of Radiology, University of Udine, University Hospital S. Maria Della Misericordia, p.le S. Maria della Misericordia n. 15, 33100, Udine, Italy.
Institute of Radiology, University Hospital S. Maria della Misericordia, p.le S. Maria della Misericordia n. 15, 33100, Udine, Italy.
Radiol Med. 2021 Nov;126(11):1407-1414. doi: 10.1007/s11547-021-01400-5. Epub 2021 Jul 24.
To compare preoperative contrast-enhanced spectral mammography (CEM) versus digital mammography plus digital breast tomosynthesis (DM + DBT) in detecting breast cancer (BC) and assessing its size.
We retrospectively included 78 patients with histological diagnosis of BC who underwent preoperative DM, DBT, and CEM over one year. Four readers, blinded to pathology and clinical information, independently evaluated DM + DBT versus CEM to detect BC and measure its size. Readers' experience ranged 3-10 years. We calculated the per-lesion cancer detection rate (CDR) and the complement of positive predictive value (1-PPV) of both methods, stratifying analysis on the total of lesions, index lesions, and additional lesions. The agreement in assessing cancer size versus pathology was assessed with Bland-Altman analysis.
100 invasive BCs (78 index lesions and 22 additional lesions) were analyzed. Compared to DM + DBT, CEM showed higher overall CDR in less experienced readers (range 0.85-0.90 vs. 0.95-0.96), and higher CDR for additional lesions, regardless of the reader (range 0.54-0.68 vs. 0.77-0.86). CEM increased the detection of additional disease in dense breasts in all readers and non-dense breasts in less experienced readers only. The 1-PPV of CEM (range 0.10-0.18) was comparable to that of DM + DBT (range 0.09-0.19). At Bland-Altman analysis, DM + DBT and CEM showed comparable mean differences and limits of agreement in respect of pathologic cancer size.
Preoperative CEM improved the detection of additional cancer lesions compared to DM + DBT, particularly in dense breasts. CEM and DM + DBT achieved comparable performance in cancer size assessment.
比较术前对比增强能谱乳腺摄影(CEM)与数字乳腺摄影加数字乳腺断层合成术(DM+DBT)在检测乳腺癌(BC)和评估其大小方面的差异。
我们回顾性纳入了 78 例经组织学诊断为 BC 的患者,这些患者在一年内接受了术前 DM、DBT 和 CEM 检查。4 名读者对 DM+DBT 与 CEM 检测 BC 和测量其大小的能力进行了独立评估,他们对病理和临床信息均不知情。读者的经验范围为 3-10 年。我们计算了两种方法的病变癌检出率(CDR)和阳性预测值的补集(1-PPV),并对总病变、索引病变和附加病变进行了分层分析。使用 Bland-Altman 分析评估了评估癌症大小与病理之间的一致性。
共分析了 100 例浸润性 BC(78 个索引病变和 22 个附加病变)。与 DM+DBT 相比,CEM 在经验较少的读者中显示出更高的总体 CDR(范围为 0.85-0.90 比 0.95-0.96),并且在所有读者中,附加病变的 CDR 更高(范围为 0.54-0.68 比 0.77-0.86)。CEM 增加了所有读者中致密乳腺的附加疾病检出率,仅在经验较少的读者中增加了非致密乳腺的检出率。CEM 的 1-PPV(范围为 0.10-0.18)与 DM+DBT 的 1-PPV(范围为 0.09-0.19)相当。在 Bland-Altman 分析中,DM+DBT 和 CEM 在病理癌症大小方面显示出可比的平均差异和一致性限制。
与 DM+DBT 相比,术前 CEM 提高了对附加癌病变的检出率,尤其是在致密乳腺中。CEM 和 DM+DBT 在评估癌症大小方面表现相当。